Targeting Tumor Stroma Using Engineered Mesenchymal Stem Cells Reduces the Growth of Pancreatic Carcinoma (vol 250, pg 747, 2009)

被引：0
|
作者：
Zischek, C.
Niess, H.
Ischenko, I.
Conrad, C.
Huss, R.
Jauch, K. W.
Nelson, P. J.
Bruns, C.
机构：
来源：
ANNALS OF SURGERY | 2010年 / 251卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：187 / 187
页数：1
相关论文
共 50 条
  • [41] The Development of a Novel Cancer Immunotherapeutic Platform Using Tumor-targeting Mesenchymal Stem Cells and a Protein Vaccine
    Wei, Hon-Jian
    Wu, Alexander T. H.
    Hsu, Chung-Huei
    Lin, Yi-Ping
    Cheng, Wen-Fang
    Su, Ching-Hua
    Chiu, Wen-Ta
    Whang-Peng, Jacqueline
    Douglas, Frank L.
    Deng, Win-Ping
    MOLECULAR THERAPY, 2011, 19 (12) : 2249 - 2257
  • [42] Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission (vol 69, pg 7507, 2009)
    Hirsch, H. A.
    Iliopoulos, D.
    Tsichlis, P. N.
    Struhl, K.
    CANCER RESEARCH, 2009, 69 (22) : 8832 - 8833
  • [43] Pharmacokinetic-Pharmacodynamic Modeling of Tumor Targeted Drug Delivery Using Nano-Engineered Mesenchymal Stem Cells
    Cheng, Shen
    Nethi, Susheel Kumar
    Al-Kofahi, Mahmoud
    Prabha, Swayam
    PHARMACEUTICS, 2021, 13 (01) : 1 - 22
  • [44] Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins (vol 4, pg 381, 2009)
    Zhou, Hongyan
    Wu, Shili
    Joo, Jin Young
    Zhu, Saiyong
    Han, Dong Wook
    Lin, Tongxiang
    Trauger, Sunia
    Bien, Geoffery
    Yao, Susan
    Zhu, Yong
    Siuzdak, Gary
    Schoeler, Hans R.
    Duan, Lingxun
    Ding, Sheng
    CELL STEM CELL, 2009, 4 (06) : 581 - 581
  • [45] ESTABLISHING AN EXPERIMENTAL MODEL FOR TARGETING RENAL CELL CARCINOMA USING MESENCHYMAL STEM CELLS IN THE AVIAN CHORIOALLANTOIC MEMBRANE
    Xu, Zhihao
    Chen, Hua
    Pink, Desmond
    Carmine-Simmen, Katia
    Lewis, John
    Moore, Ronald
    JOURNAL OF UROLOGY, 2016, 195 (04): : E923 - E923
  • [46] Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer Growth
    Hintz, Hallie M.
    Snyder, Kristin M.
    Wu, Jianming
    Hullsiek, Robert
    Dahlvang, James D.
    Hart, Geoffrey T.
    Walcheck, Bruce
    LeBeau, Aaron M.
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (11) : 1270 - 1282
  • [47] Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model (vol 549, pg 218, 2018)
    Shamili, Fazileh Hosseini
    Bayegi, Houshang Rafatpanah
    Salmasi, Zahra
    Sadri, Kayvan
    Mahmoudi, Mahmoud
    Kalantari, Mahmoudreza
    Ramezani, Mohammad
    Abnous, Khalil
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, 558 : 441 - 441
  • [48] Reduction of lung metastasis by engineered Mesenchymal stem cells expressing secreted soluble TRAIL (vol 63, pg A66, 2013)
    Yuan, Z. Q.
    Kolluri, K.
    Janes, S. M.
    THORAX, 2014, 69 (03)
  • [49] Targeting cancer stem cells by a novel anti-frizzled antibody inhibits pancreatic tumor growth and induces differentiation
    Yen, Wan-Ching
    Fischer, Marcus
    Lewicki, John
    Gurney, Austin
    Hoey, Timothy
    CANCER RESEARCH, 2011, 71
  • [50] Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma
    Chen, Jiang
    Ji, Tong
    Wu, Di
    Jiang, Shi
    Zhao, Jie
    Cai, Xiujun
    Lin, Hui
    CELL DEATH & DISEASE, 2019, 10 (6)
12345